|
Volumn 34, Issue 11, 1994, Pages 1036-1042
|
Drug chirality: On the mechanism of R-aryl propionic acid class NSAIDs. Epimerization in humans and the clinical implications for the use of racemates
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENOXAPROFEN;
DRUG METABOLITE;
EPIMERASE;
FENOPROFEN;
FLURBIPROFEN;
IBUPROFEN;
KETOPROFEN;
LONG CHAIN FATTY ACID COENZYME A LIGASE;
NAPROXEN;
PALMITOYL COENZYME A HYDROLASE;
CHIRALITY;
DRUG CLEARANCE;
DRUG CONFORMATION;
DRUG ELIMINATION;
DRUG METABOLISM;
ENZYME ACTIVITY;
HUMAN;
LIPID SOLUBILITY;
LIVER MICROSOME METABOLISM;
LIVER TOXICITY;
NONHUMAN;
RACEMIC MIXTURE;
REVIEW;
STRUCTURE ACTIVITY RELATION;
STRUCTURE ANALYSIS;
|
EID: 0028149258
PISSN: 00912700
EISSN: None
Source Type: Journal
DOI: 10.1002/j.1552-4604.1994.tb01977.x Document Type: Review |
Times cited : (59)
|
References (0)
|